Clinical Features of Glanzmann Thrombasthenia
Glanzmann thrombasthenia presents primarily with mucocutaneous bleeding starting in early childhood, characterized by epistaxis, easy bruising, gingival bleeding, and menorrhagia in females, with bleeding severity varying markedly between patients despite similar laboratory findings. 1, 2
Age of Presentation and Demographics
- Median age at presentation: 3 years (ranging from birth to 14 years) 1
- Strong association with consanguineous marriages (55-65% of cases), particularly in populations with high rates of consanguinity including Indians, Iranians, Iraqi Jews, Palestinian and Jordanian Arabs, and French Gypsies 1, 3, 4
- No significant gender predominance, though some series show slight male preponderance (M:F ratio 1.2:1) 3
Bleeding Manifestations
Most Common Presenting Symptoms (in order of frequency):
- Epistaxis (39-62.5%) - the most frequent initial presentation 1, 3
- Cutaneous bleeding/Easy bruising (30-76.6%) - extensive ecchymoses from minor trauma 1, 5, 3
- Gingival bleeding (10-56.4%) - spontaneous or with minor trauma 1, 3
- Gastrointestinal bleeding (23%) 1
- Menorrhagia (19.5%) - in post-menarchal females 1
- Post-circumcision bleeding (5.7%) - in males 1
Severe Bleeding Complications:
- Intracranial hemorrhage - rare but life-threatening (1.1% as initial presentation) 1, 6
- Chronic subdural hematoma - can occur even after mild head trauma 6
- Hemarthrosis - less common than in coagulation factor deficiencies 4
- Hematuria 4
- Major bleeding with surgical procedures or trauma 5, 2
Physical Examination Findings
The ISTH guidelines emphasize that physical examination should specifically assess for 7:
- Bleeding manifestations typical of inherited platelet function disorders (petechiae, purpura, ecchymoses)
- Absence of syndromic features - GT typically does NOT present with hearing loss, cardiac abnormalities, facial dysmorphisms, ocular involvement, mental retardation, or skin discoloration (these suggest other platelet disorders)
- Normal platelet size on blood smear - distinguishes GT from Bernard-Soulier Syndrome
Critical Clinical Pitfalls
Important caveat: There is NO significant correlation between GT subtype (Type I, II, or III based on CD41/CD61 expression) and bleeding severity or clinical phenotype 1. This means you cannot predict bleeding risk based on laboratory classification alone - clinical assessment of individual bleeding history is paramount.
Diagnostic Delay
GT is significantly underdiagnosed with substantial delays in diagnosis 1. The median age at presentation of 3 years suggests many patients experience bleeding episodes before formal diagnosis, emphasizing the need for high clinical suspicion in children with unexplained mucocutaneous bleeding.
Bleeding Assessment
Use a bleeding assessment tool (BAT) to quantify symptom severity - while the ISTH-BAT has not been sufficiently validated specifically in inherited platelet function disorders, structured bleeding assessment helps identify patients requiring further investigation 7.
Key Historical Elements to Elicit:
- Unexplained or extensive bruising from minor trauma
- Epistaxis requiring medical intervention
- Menorrhagia (quantify with pictorial charts if possible)
- Bleeding during childbirth
- Bleeding following invasive procedures and dental extractions
- Family history - autosomal recessive pattern, consanguinity 7
- Drug/food intake that could interfere with platelet function (must exclude acquired causes)
Clinical Severity Spectrum
Bleeding severity varies markedly between patients 8, 9, ranging from:
- Mild: Occasional epistaxis and bruising
- Moderate: Frequent mucocutaneous bleeding requiring medical attention
- Severe: Life-threatening hemorrhage (intracranial, gastrointestinal), bleeding requiring hospitalization
The average hospital stay for bleeding episodes is 8 days 5, reflecting the significant morbidity associated with this disorder.